ClinicalTrials.gg
CompletedNCT03303118HypoxiaUpdated Aug 18, 2021

The Effects of Hypobaria vs Hypoxia on Cerebral Functions.

An interventional study of Hypoxia in Cerebral Hypoxia, sponsored by Fliegerärztliches Institut. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-18.

Sponsored by Fliegerärztliches Institut · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Not applicable
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The investigators will investigate the effect of hypobaria and hypoxia on physiological responses such as: oxygen saturation, heart rate, cerebral blood flow, cerebral oxygenation, brain's activity and concentration performance.

Read the detailed description

The main goal of this project is to investigate how hypoxia affects cognitive functions. The KLT-R test asses the concentration level of a person. Subjects will do this test at different simulated altitude level in the hypobaric chamber at the FAI in Dübendorf. Investigators' first hypothesis is that concentration level will be altered by hypoxia. The higher altitude the subjects are, the more the concentration would be altered. KLT-R performance would be impaired by hypoxia compare to sea level performance.

The primary endpoint of this project is to investigate how KLT-R performance is affected by the different hypoxic conditions. KLT-R test will be passed nine times in total during the test visit. There will be a pre-test; a test at each of the conditions (3000m HH, 5500m HH, 5500m NH and 5500m HN); between each condition at sea level (to have a new baseline before each condition) and a post-test at the end of the protocol. To avoid influence of fatigue, all conditions will be randomized.

The second endpoint of this study is how the brain electrical activity is modulated by hypoxia. Micro-states also will be measure during hypobaric hypoxia conditions (3000m HH and 5500m HH).

02

Conditions studied

  • Cerebral Hypoxia

Keywords

  • Hypoxia
  • Brain
  • Cerebral vaso-reactivity
  • EEG
  • Concentration performance
  • Cerebral oxygenation
  • Cerebral blood-flow
  • Heart rate variability
03

In context

Hypoxia, Brain

81 studies on the registry are indexed under Hypoxia, Brain; 19 are open to participants now.

This study's enrollment of 17 is below the median of 60 across 55 interventional studies indexed under Hypoxia, Brain.

Browse Hypoxia, Brain studies →

Lead sponsor

Fliegerärztliches Institut is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • No history of flight sickness
  • No relevant medical diseases
  • Age 18 - 40 years
  • Written consent acceptance

Exclusion criteria

Exclusion Criteria:

  • Known pathologies
  • Relevant medical disorders
  • Drug addiction
  • Anemia or poor health
  • People who have already had problems with elevation
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
17 participants (actual)

Study arms

  • Other
    Left

    No product administration will be done in this study.

    Other: Hypoxia

Interventions

  • OtherHypoxia

    No drug or product will be used in this study. No medication will be give to the participants. No arm will be used for product administration.

06

What researchers measure

Primary outcomes

  1. Concentration performance

    Performance of concentration at different altitude levels.

    Time frame: 4 minutes per test

Secondary outcomes

  1. EEG micro-states

    5 minutes recording in each conditions, eyes closed, at rest.

    Time frame: 5 minutes per record

Other outcomes

  1. Cerebral vaso-reactivity

    Cerebral vasoreactivity after 1 minute hyperventilation and 3 minutes breathing of 5% CO2 mixture.

    Time frame: 8 Minutes per test

07

Study locations

1 site
  • Mathias Aebi
    Dübendorf, Zürich 8600, Switzerland
08

References and documents

Publications

  • Aebi MR, Bourdillon N, Kunz A, Bron D, Millet GP. Specific effect of hypobaria on cerebrovascular hypercapnic responses in hypoxia. Physiol Rep. 2020 Feb;8(4):e14372. doi: 10.14814/phy2.14372. PubMed 32097541 ↗

Individual participant data

Plan to share: No — Results will be shared in scientific publications by the end of this year and in 2018.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2017 to primary completion in Mar 2018, 3 months.

Of 33 non-industry interventional studies with no phase under Hypoxia, Brain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 44. This study's 3 months is below that.

Counting every sponsor, half of 33 studies reached it within 20 months; a quarter within 7 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2017
First posted
Oct 5, 2017
StartActual
Nov 16, 2017
Primary completionActual
Mar 5, 2018
CompletionActual
Mar 5, 2018
Last update
Aug 18, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 18, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03303118
Lead sponsor
Fliegerärztliches Institut
Responsible party
Mathias Aebi, PhD (Dr. med Denis Bron, Fliegerärztliches Institut) — Principal investigator
First posted
Oct 5, 2017
Start date
Nov 16, 2017
Primary completion
Mar 5, 2018
Completion
Mar 5, 2018
Last update
Aug 18, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion